SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,518,334 | -25.2% | 173,439 | +7.8% | 0.00% | 0.0% |
| Q2 2023 | $3,368,621 | +105367.2% | 160,947 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $3,194 | -13.3% | 151,237 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $3,686 | -99.9% | 144,862 | -12.7% | 0.00% | -50.0% |
| Q3 2022 | $3,986,000 | +24.9% | 165,877 | +0.0% | 0.00% | +100.0% |
| Q2 2022 | $3,191,000 | +15.1% | 165,842 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $2,773,000 | -5.4% | 163,590 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $2,932,000 | -15.2% | 163,861 | -6.2% | 0.00% | 0.0% |
| Q3 2021 | $3,458,000 | -7.2% | 174,670 | -19.5% | 0.00% | 0.0% |
| Q2 2021 | $3,725,000 | +20.6% | 216,914 | +57.0% | 0.00% | 0.0% |
| Q1 2021 | $3,090,000 | -11.1% | 138,191 | -11.6% | 0.00% | 0.0% |
| Q4 2020 | $3,477,000 | +26.2% | 156,338 | -16.2% | 0.00% | 0.0% |
| Q3 2020 | $2,755,000 | +58.4% | 186,641 | +59.1% | 0.00% | 0.0% |
| Q2 2020 | $1,739,000 | +111.0% | 117,303 | +56.3% | 0.00% | – |
| Q1 2020 | $824,000 | +5.2% | 75,037 | -15.8% | 0.00% | – |
| Q4 2019 | $783,000 | -29.6% | 89,156 | -40.2% | 0.00% | – |
| Q3 2019 | $1,113,000 | +9.4% | 148,988 | +36.4% | 0.00% | – |
| Q2 2019 | $1,017,000 | – | 109,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
| Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
| Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
| Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
| Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
| DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
| COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
| Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |